Committed to Helping You Get Your Medicine

Knowing what to expect can make all the difference. We can help you through each step of getting RITUXAN HYCELA.

Frequently Asked Questions

About Genentech BioOncology® Access Solutions

Genentech BioOncology Access Solutions is a resource for people who take RITUXAN HYCELA. We connect you to the medicine you need.

I Am Concerned About Paying for RITUXAN HYCELA

There may be options to help you get the RITUXAN HYCELA your doctor has prescribed. Genentech BioOncology Access Solutions can refer you to patient assistance options.

We have changed the name of GATCF to the Genentech Patient Foundation. We made this change to show our commitment to helping patients and to make it easier to remember.

Getting My Medicine

You can’t get RITUXAN HYCELA from your local pharmacy. Instead, it will come to you from a specialty pharmacy.

Your specialty pharmacy is different from your regular mail-order pharmacy. It handles drugs like RITUXAN HYCELA.

When we check your coverage, we also refer you to a specialty pharmacy your health insurance plan will cover.

You might not be able to get RITUXAN HYCELA right away. First, your doctor’s office or specialty pharmacy will have to check to make sure your health insurance plan covers your medicine. This is called a “benefits investigation.” They also might have to send some more information before your plan covers your medicine. This is called a “prior authorization.”

Enrolling in Genentech BioOncology Access Solutions

  1. You fill out a form called the PAN.
  2. Your doctor fills out a form called the Prescriber Service Form. You do not have to fill out anything on this form.
  3. Your doctor sends both of these forms to Genentech BioOncology Access Solutions.

There are 2 ways to fill out the PAN form:

  • You can fill out the form online 
  • You can download and print it to fill out a paper copy

The PAN form lets us discuss your health information with your doctor and your health insurance plan. We can’t work with you without a signed PAN.

You do not need to do anything else, but your doctor does. He or she needs to submit a form called the Prescriber Service Form. This form tells us your doctor wants to treat you with RITUXAN HYCELA. Make sure your doctor has sent us the Prescriber Service Form so you get help from us.

You do not need to fill out anything on the Prescriber Service Form.

My Health Plan Denied Coverage for RITUXAN HYCELA

If your health insurance plan will not cover RITUXAN HYCELA, you and your doctor'€™s office can file an appeal. Contact your doctor to ask if you should file an appeal.

We have resources to help you and your doctor file an appeal.

We have resources to help you and your doctor file an appeal. You or your doctor’s office has to file the appeal directly with your health insurance plan.

This depends on your health insurance plan. You should ask your plan directly about its process. Sometimes the appeals process is quick. However, it can take several months if you have to appeal several times.

My Insurance Might Change

If your insurance changes while you’re taking RITUXAN HYCELA, call us. We can help you understand your new coverage.

The Genentech Patient Foundation gives free RITUXAN HYCELA to people who don't have insurance coverage or who have financial concerns and to people who meet certain income criteria.

It is your and your doctor's responsibility to complete and submit all required paperwork to your health insurance plan. Genentech and Biogen cannot guarantee your plan will cover any treatments.

PAN=Patient Authorization and Notice of Request for Transmission of Health Information to Genentech Access Solutions and Genentech® Access to Care Foundation.

Important Safety Information & Indication

See More Back to Top

What it Treats

Indications

RITUXAN HYCELA® (rituximab/hyaluronidase human) is a prescription medicine used to treat adults with:

  • Follicular Lymphoma (FL) as a single-agent therapy in patients whose disease recurred or did not respond to initial treatment
  • Follicular Lymphoma as an initial treatment with chemotherapy and, in patients whose initial treatment was successful, as a single-agent follow-up therapy
  • Follicular Lymphoma as a single agent follow-up therapy for patients who did not progress on initial treatment with CVP chemotherapy
  • Diffuse Large B-Cell Lymphoma (DLBCL) as an initial treatment in combination with CHOP or other anthracycline-based chemotherapy regimens
  • Chronic Lymphocytic Leukemia (CLL) in combination with FC chemotherapy as an initial treatment or as a treatment after disease has recurred

You can only receive RITUXAN HYCELA after you receive at least 1 full dose of intravenous (IV) RITUXAN® (rituximab). Read the IV RITUXAN Medication Guide for more information about severe infusion reactions, which usually happen during the first dose with IV RITUXAN.

RITUXAN HYCELA is not for use to treat medical conditions other than cancers.

It is not known if RITUXAN HYCELA is safe and effective in children.

Important Safety Information

What is the most important information I should know about RITUXAN HYCELA?

RITUXAN HYCELA can cause serious side effects that can lead to death, including:

  • Severe skin and mouth reactions: Tell your healthcare provider or get medical help right away if you get any of these symptoms at any time during your treatment with RITUXAN HYCELA: painful sores or ulcers on your skin, lips, or in your mouth; blisters; peeling skin; rash or pustules.
  • Hepatitis B virus (HBV) reactivation: Before you receive RITUXAN HYCELA, your doctor will do blood tests to check for HBV infection. If you have had hepatitis B or are a carrier of hepatitis B virus, receiving RITUXAN HYCELA could cause the virus to become an active infection again. Hepatitis B reactivation may cause serious liver problems including liver failure and death. Your healthcare provider will monitor you for hepatitis B infection during and for several months after you stop receiving RITUXAN HYCELA. Tell your healthcare provider right away if you get worsening tiredness, or yellowing of your skin or white part of your eyes during treatment with RITUXAN HYCELA.
  • Progressive Multifocal Leukoencephalopathy (PML): PML is a rare, serious brain infection caused by a virus that can happen in people who receive RITUXAN HYCELA. People with weakened immune systems can get PML. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML. Tell your healthcare provider right away if you have any new or worsening symptoms or if anyone close to you notices these symptoms: confusion; dizziness or loss of balance; difficulty walking or talking; decreased strength or weakness on one side of your body; vision problems, such as blurred or loss of vision.
  • Serious allergic reactions and other severe reactions:
    Serious allergic reactions, and reactions due to release of certain substances by the body that can lead to death, can happen with rituximab products, including RITUXAN HYCELA.

Skin reactions at or near the injection site (local), including injection site reactions can happen with RITUXAN HYCELA. Symptoms at or near the injection site may include: pain, swelling, hardness, redness, bleeding, itching, and rash. These reactions sometimes happen more than 24 hours after an injection of RITUXAN HYCELA.

Tell your healthcare provider or get medical help right away if you get any of these symptoms during or after an injection of RITUXAN HYCELA: hives (red itchy welts) or rash; itching; swelling of your lips, tongue, throat, or face; sudden cough; shortness of breath, difficulty breathing, or wheezing; weakness; dizziness or feeling faint; palpitations (feeling like your heart is racing or fluttering); chest pain; fever; chills or shaking chills.

What are possible side effects of RITUXAN HYCELA?

RITUXAN HYCELA can cause serious side effects, including:

  • Tumor Lysis Syndrome (TLS): TLS is caused by the fast breakdown of cancer cells. TLS can cause you to have kidney failure, the need for dialysis treatment, and an abnormal heart rhythm. TLS can happen within 12 to 24 hours after an injection of RITUXAN HYCELA. Your healthcare provider may do blood tests to check you for TLS. Your healthcare provider may give you medicine to help prevent TLS. Tell your healthcare provider right away if you have any of the following signs or symptoms of TLS: nausea, vomiting, diarrhea, or lack of energy.
  • Serious Infections: Serious infections can happen during and after treatment with RITUXAN HYCELA and can lead to death. Rituximab products can increase your risk of getting infections and can lower the ability of your immune system to fight infections. Types of serious infections that can happen with RITUXAN HYCELA include bacterial, fungal, and viral infections. After receiving RITUXAN HYCELA, some people have developed low levels of certain antibodies in their blood for a long period of time (longer than 11 months). Some of these people with low antibody levels developed infections. Tell your healthcare provider right away if you have any symptoms of infection: fever; cold symptoms, such as runny nose or sore throat that do not go away; flu symptoms, such as cough, tiredness, and body aches; earache or headache; pain during urination; white patches in the mouth or throat; cuts, scrapes, or incisions that are red, warm, swollen, or painful.
  • Heart Problems: RITUXAN HYCELA may cause chest pain, irregular heartbeats, and heart attack. Your healthcare provider may monitor your heart during and after treatment with RITUXAN HYCELA if you have symptoms of heart problems or have a history of heart problems. Tell your healthcare provider right away if you have chest pain or irregular heartbeats during treatment with RITUXAN HYCELA.
  • Kidney Problems: RITUXAN HYCELA can cause severe kidney problems that can lead to death. Your healthcare provider should do blood tests to check how well your kidneys are working.
  • Stomach and serious bowel problems that can sometimes lead to death: Bowel problems, including blockage or tears in the bowel, can happen if you receive RITUXAN HYCELA with chemotherapy medicines. Tell your healthcare provider right away if you have severe stomach-area (abdomen) pain or repeated vomiting during treatment with RITUXAN HYCELA.

Your healthcare provider will stop treatment with RITUXAN HYCELA if you have severe, serious, or life-threatening side effects.

The most common side effects of RITUXAN HYCELA in people with:

  • FL: infections, low white blood cell count, nausea, constipation, cough, and tiredness.
  • DLBCL: infections, low white blood cell count, loss of hair, nausea, and low red blood cell count.
  • CLL: infections, low white blood cell count, nausea, low platelet count, fever, vomiting, and injection site redness.

Additional Important Safety Information

Before receiving RITUXAN HYCELA, tell your healthcare provider about all of your medical conditions, including if you:

  • Have had a severe reaction to a rituximab product or RITUXAN HYCELA.
  • Have had a recent vaccination or are scheduled to receive vaccinations. You should not receive certain vaccines before or during treatment with RITUXAN HYCELA.
  • Are pregnant, plan to become pregnant, are breastfeeding, or plan to breastfeed. Talk to your healthcare provider about the risks to your unborn baby if you receive RITUXAN HYCELA during pregnancy. Females who are able to become pregnant should use effective birth control (contraception) during treatment with RITUXAN HYCELA and for 12 months after the last dose of RITUXAN HYCELA. Talk with your healthcare provider about effective birth control. It is not known if RITUXAN HYCELA passes into your breast milk. Do not breastfeed during treatment and for at least 6 months after your last dose of RITUXAN HYCELA.

These are not all of the possible side effects with RITUXAN HYCELA. Call your doctor for medical advice about side effects.

Please see the full Prescribing Information, including BOXED WARNINGS and Medication Guide, for additional Important Safety Information.

You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.